Paradigm Biopharmaceuticals Limited
PBIGF
$0.2083
$0.00633.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.95% | -20.65% | -68.23% | -69.18% | -59.91% |
| Total Receivables | -22.08% | -7.78% | -25.15% | -27.39% | 2,706.32% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.57% | 43.87% | 118.16% | 111.63% | -10.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -29.91% | -17.05% | -61.88% | -63.02% | -50.73% |
|
|
|||||
| Total Current Assets | -29.91% | -17.05% | -61.88% | -63.02% | -50.73% |
| Net Property, Plant & Equipment | -59.23% | -51.74% | -43.50% | -45.17% | -36.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.22% | 7.45% | 0.24% | -2.75% | 0.29% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -28.73% | -15.65% | -59.06% | -60.28% | -48.96% |
|
|
|||||
| Total Accounts Payable | -94.72% | -93.75% | -76.74% | -77.44% | 190.31% |
| Total Accrued Expenses | -54.22% | -45.84% | -46.17% | -47.78% | -92.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.72% | -22.85% | 16.31% | 12.93% | 11.40% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -91.05% | -89.41% | -74.18% | -74.95% | -24.20% |
|
|
|||||
| Total Current Liabilities | -91.05% | -89.41% | -74.18% | -74.95% | -24.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -48.72% | -39.32% | -50.22% | -51.73% | -38.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.27% | -4.53% | -4.93% | -7.79% | 40.86% |
| Total Liabilities | -89.49% | -87.56% | -73.17% | -73.97% | -24.04% |
|
|
|||||
| Common Stock & APIC | -3.45% | 14.27% | 13.76% | 10.35% | 13.96% |
| Retained Earnings | 4.30% | -13.26% | -35.32% | -31.28% | -47.15% |
| Treasury Stock & Other | -50.74% | -41.70% | -12.49% | -15.11% | -11.58% |
| Total Common Equity | -8.53% | 8.26% | -55.54% | -56.87% | -53.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.53% | 8.26% | -55.54% | -56.87% | -53.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.53% | 8.26% | -55.54% | -56.87% | -53.98% |
|
|
|||||